Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Current Opinion in Hematology|December 6, 2008
Antibiotics for the prevention of febrile neutropeniaJennifer Pascoe, Neil StevenThe Lancet. Oncology|February 13, 2016
Research methods to change clinical practice for patients with rare cancersLucinda Billingham, Kinga Malottki, Neil StevenJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 24, 2022
Management of immune-related hepatitis in patients being treated with checkpoint inhibitors for metastatic melanoma, a review and case seriesAlice Tew, Leila Khoja, Lalit Pallan, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 23, 2024
Evaluation of colitis induced by immune-checkpoint inhibitors therapy in melanoma patients by an overall grading scaleTrang L Nguyen, Alice Tew, Laura Kirton, et al.Case Reports in Oncological Medicine|May 10, 2022
Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma PatientP Kissoonsingh, B Sutton, Syed U Iqbal, et al.BMC Cancer|July 12, 2021
Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell, et al.Blood|February 28, 2004
Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigenPhilip Savage, Liquan Gao, Kevin Vento, et al.Cancer Immunology, Immunotherapy : CII|December 7, 2007
Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responsesRichard Harrop, Noel Drury, William Shingler, et al.Proteome Science|June 19, 2008
Proteomic profiling of urine for the detection of colon cancerDouglas G Ward, Stephen Nyangoma, Howard Joy, et al.Blood|July 19, 2003
Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantationSuparno Chakrabarti, Donald W Milligan, Deenan Pillay, et al.Pageof 3